{
  "url": "https://www.law.cornell.edu/regulations/new-york/4-NYCRR-83.2",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 4 ยง 83.2 - Definitions",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 4 ยง 83.2 - Definitions\n\nState Regulations\n\nFor the purposes of this Part: (a) The term department or Department of\n\nCivil Service means the New York State Department of Civil Service. (b) The term AIDS means acquired immune\ndeficiency syndrome, as may be defined from time to time by the centers for\ndisease control of the United States Public Health Service. (c) The term HIV infection means infection\nwith the human immunodeficiency virus or any other related virus identified as\na probable causative agent of AIDS. (d) The term HIV related illness means any\nillness that may result from or may be associated with HIV infection. (e) The term HIV related test means any\nlaboratory test or series of tests for any virus, antibody, antigen or\netiologic agent whatsoever thought to cause or to indicate the presence of\nHIV/AIDS. (f) The term confidential\nHIV related information means any information concerning whether an individual\nhas been the subject of an HIV related test, or has HIV infection, HIV related\nillness or AIDS, or information which identifies or reasonably could identify\nan individual as having one or more of such conditions, including information\npertaining to such individual's contacts. (g) The term contact means an identified\nspouse or sex partner of the protected individual or a person identified as\nhaving shared hypodermic needles or syringes with the protected\nindividual. (h) The term\nsignificant risk of transmitting or contracting HIV infection or significant\nrisk includes the following circumstances: (1)\nsexual contact which exposes a mucous membrane or broken skin of a noninfected\nindividual to blood, semen or vaginal secretions of an infected\nindividual; (2)\nsharing of needles\nor other paraphernalia used for preparing and injecting drugs between infected\nand noninfected individuals; (3)\nthe gestation, birthing or breast feeding of an infant when the mother is\ninfected with HIV; (4)\ntransfusion\nor transplantation of blood, organs, or other tissues obtained from an infected\nindividual to an uninfected individual, provided that such products have not\ntested negatively for antibody or antigen and have not been rendered\nnoninfective by heat or chemical treatment; (5)\nother circumstances, not identified in\nparagraphs (1) through (4) of this subdivision, during which a significant risk\nbody substance (other than breast milk) of an infected person contacts mucous\nmembranes (e.g., eyes, nose, mouth) or nonintact skin (e.g., open wound, dermatitis, abraded areas) or the vascular system of a noninfected\nperson; (6)\ncircumstances that\nconstitute significant risk shall not include: (i) exposure to urine, feces, sputum, nasal\nsecretions, saliva, sweat, tears or vomitus that does not contain visible\nblood; (ii)\nhuman bites where there\nis no direct blood to blood, or blood to mucous membrane contact; (iii)\nexposure of intact skin to blood or any\nother body substance; and\n(iv)\noccupational settings where individuals use scientifically accepted barrier\ntechniques and preventing practices in circumstances which would otherwise pose\na significant risk. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 4\nยง\n83.2\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 16175
}